MedTrace Logo

Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

NCT05834270 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-04-28

No results posted yet for this study

Summary

Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia

Conditions

  • Prostatic Neoplasms
  • Prostate Disease
  • Prostate Obstruction
  • Prostate Hypertrophy

Interventions

DRUG

Single dose tamsulosin 0.4mg

Single dose tamsulosin 0.4mg

DRUG

Double dose tamsulosin 0.4mg

Double dose tamsulosin 0.4mg

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-01
Primary Completion
2022-12-01
Completion
2022-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05834270 on ClinicalTrials.gov